Cargando…

A systematic quality rating of available mobile health apps for borderline personality disorder

BACKGROUND: Mobile health apps (MHAs) may offer a mean to overcome treatment barriers in Borderline Personality Disorder (BPD) mental health care. However, MHAs for BPD on the market lack transparency and quality assessment. METHODS: European app stores were systematically searched, and two independ...

Descripción completa

Detalles Bibliográficos
Autores principales: Steubl, Lena Sophia, Reimann, Josephin, Simon, Laura, Terhorst, Yannik, Stach, Michael, Baumeister, Harald, Sander, Lasse Bosse, Messner, Eva-Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158356/
https://www.ncbi.nlm.nih.gov/pubmed/35642024
http://dx.doi.org/10.1186/s40479-022-00186-w
_version_ 1784718820102897664
author Steubl, Lena Sophia
Reimann, Josephin
Simon, Laura
Terhorst, Yannik
Stach, Michael
Baumeister, Harald
Sander, Lasse Bosse
Messner, Eva-Maria
author_facet Steubl, Lena Sophia
Reimann, Josephin
Simon, Laura
Terhorst, Yannik
Stach, Michael
Baumeister, Harald
Sander, Lasse Bosse
Messner, Eva-Maria
author_sort Steubl, Lena Sophia
collection PubMed
description BACKGROUND: Mobile health apps (MHAs) may offer a mean to overcome treatment barriers in Borderline Personality Disorder (BPD) mental health care. However, MHAs for BPD on the market lack transparency and quality assessment. METHODS: European app stores were systematically searched, and two independent trained reviewers extracted relevant MHAs. Employed methods and privacy and security details documentation of included MHAs were extracted. MHAs were then assessed and rated using the German version of the standardized Mobile Application Rating Scale (MARS-G). Mean values and standard deviations of all subscales (engagement, functionality, aesthetics, information, and therapeutic gain) and correlations with user ratings were calculated. RESULTS: Of 2977 identified MHAs, 16 were included, showing average quality across the four main subscales (M = 3.25, SD = 0.68). Shortcomings were observed with regard to engagement (M = 2.87, SD = 0.99), potential therapeutic gain (M = 2.67, SD = 0.83), existing evidence base (25.0% of included MHAs were tested empirically), and documented privacy and security details. No significant correlations were found between user ratings and the overall total score of the MARS-G or MARS-G main subscales. CONCLUSIONS: Available MHAs for BPD vary in quality and evidence on their efficacy, effectiveness, and possible adverse events is scarce. More substantial efforts to ensure the quality of MHAs available for patients and a focus on transparency, particularly regarding privacy and security documentation, are necessary. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40479-022-00186-w.
format Online
Article
Text
id pubmed-9158356
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91583562022-06-02 A systematic quality rating of available mobile health apps for borderline personality disorder Steubl, Lena Sophia Reimann, Josephin Simon, Laura Terhorst, Yannik Stach, Michael Baumeister, Harald Sander, Lasse Bosse Messner, Eva-Maria Borderline Personal Disord Emot Dysregul Research Article BACKGROUND: Mobile health apps (MHAs) may offer a mean to overcome treatment barriers in Borderline Personality Disorder (BPD) mental health care. However, MHAs for BPD on the market lack transparency and quality assessment. METHODS: European app stores were systematically searched, and two independent trained reviewers extracted relevant MHAs. Employed methods and privacy and security details documentation of included MHAs were extracted. MHAs were then assessed and rated using the German version of the standardized Mobile Application Rating Scale (MARS-G). Mean values and standard deviations of all subscales (engagement, functionality, aesthetics, information, and therapeutic gain) and correlations with user ratings were calculated. RESULTS: Of 2977 identified MHAs, 16 were included, showing average quality across the four main subscales (M = 3.25, SD = 0.68). Shortcomings were observed with regard to engagement (M = 2.87, SD = 0.99), potential therapeutic gain (M = 2.67, SD = 0.83), existing evidence base (25.0% of included MHAs were tested empirically), and documented privacy and security details. No significant correlations were found between user ratings and the overall total score of the MARS-G or MARS-G main subscales. CONCLUSIONS: Available MHAs for BPD vary in quality and evidence on their efficacy, effectiveness, and possible adverse events is scarce. More substantial efforts to ensure the quality of MHAs available for patients and a focus on transparency, particularly regarding privacy and security documentation, are necessary. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40479-022-00186-w. BioMed Central 2022-06-01 /pmc/articles/PMC9158356/ /pubmed/35642024 http://dx.doi.org/10.1186/s40479-022-00186-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Steubl, Lena Sophia
Reimann, Josephin
Simon, Laura
Terhorst, Yannik
Stach, Michael
Baumeister, Harald
Sander, Lasse Bosse
Messner, Eva-Maria
A systematic quality rating of available mobile health apps for borderline personality disorder
title A systematic quality rating of available mobile health apps for borderline personality disorder
title_full A systematic quality rating of available mobile health apps for borderline personality disorder
title_fullStr A systematic quality rating of available mobile health apps for borderline personality disorder
title_full_unstemmed A systematic quality rating of available mobile health apps for borderline personality disorder
title_short A systematic quality rating of available mobile health apps for borderline personality disorder
title_sort systematic quality rating of available mobile health apps for borderline personality disorder
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158356/
https://www.ncbi.nlm.nih.gov/pubmed/35642024
http://dx.doi.org/10.1186/s40479-022-00186-w
work_keys_str_mv AT steubllenasophia asystematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder
AT reimannjosephin asystematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder
AT simonlaura asystematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder
AT terhorstyannik asystematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder
AT stachmichael asystematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder
AT baumeisterharald asystematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder
AT sanderlassebosse asystematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder
AT messnerevamaria asystematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder
AT steubllenasophia systematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder
AT reimannjosephin systematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder
AT simonlaura systematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder
AT terhorstyannik systematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder
AT stachmichael systematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder
AT baumeisterharald systematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder
AT sanderlassebosse systematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder
AT messnerevamaria systematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder